Ashiq Mubarack

Stock Analyst at Citigroup

(0)
# 3992
Out of 5,248 analysts
3
Total ratings
66.67%
Success rate
-3.27%
Average return
Main Sectors:
Top Industries:
2 Stocks
Name Action Price Target Current % Upside Ratings Updated
Mersana Therapeutics
Maintains: Buy
6 5
0.53 843.4% 2 Aug 27, 2024
Alpha Tau Medical
Initiates Coverage On: Buy
8
4 100% 1 Dec 15, 2023